Recall of Losartan

By Bryan Tan Van Hong
Publicity Associate at YPC. Currently working in Esyms, an online pharmacy platform and Registered Pharmacist at a retail pharmacy. Oh, and not to forget, pun enthusiast.

On early March, the Ministry of Health Malaysia released a statement regarding the recall of 7 types of medication containing the active ingredient Losartan. This came about after some of these angiotension II receptor blocker (ARB) were found to contain unacceptable amount of nitrosamine, a substance which is possibly carcinogenic, or has the potential to cause cancer.
The seven types of medications recalled were Losagen 50, Losagen 100, Losartas 50mg Tablets, Losartas 100mg Tablets, Tozaar Plus LS 50/12.5mg Tablet, Tozaar 50mg Tablet and Tozaar Tablet 100mg.
Deputy Minister Dr Lee Boon Chye urged those who are in possession of the aforementioned medication to return it to the supplier in exchange for other approved medication. Stern actions will also be taken on suppliers who continue to sell these medications.
However, there is no need to panic, says Dr Lee. “Do not panic if you have consumed the medications, as there are no short-term effects.”
This is not the first time losartan has been recalled from the market. Last year, a similar incident occured where the company which supplied Lostad HCT 50/12.5 mg was asked to cease its operation.
Be sure to visit your local pharmacy or clinic for any enquiries. Do not stop taking any medications on your own accord.
Related
COVID-19 Pandemic Guidance Document Version 1 (March 2020)
Last updated onIn light of COVID-19 and the resultant rapid expansion of pharmacists’ roles, Malaysian Pharmaceutical Society has released a guideline for Malaysian pharmacists. COVID-19 Pandemic Guidance Document for Malaysian Pharmacists Version 1 (March 2020) outlines 3 main points that pharmacists can take to ensure optimum participation in the crisis together with other healthcare professionals. The main…
Malaysian Clinical Pharmacy Symposium (MCPS) 2.5
Last updated onWritten by Tang Jia Wen, commitee member of MCPS 2.5 On 27 July 2019, the Malaysian Clinical Pharmacy Symposium (MCPS) 2.5 – A Cancer Therapy Counselling Workshop was held in International Medical University (IMU). It had successfully gathered pharmacists from different backgrounds and provided a conducive platform for them to exchange ideas and thoughts…
Stable Coronary Artery Disease (2nd Edition)
Last updated onNDMA Found in Ranitidine
Last updated onWritten by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast Recently, there has been news regarding the discovery of traces of N-Nitrosodimethylamin (NDMA) found in ranitidine medications. This was reported by the American-based Food and Drug Administration (FDA) as well as the Singaporean…
Since our last article on COVID-19, so much has changed-the number of reported cases, better understanding of the virus’ characteristics, and its rebranding to COVID-19. After a harrowing month into the new decade, there’s finally some good news in 2020! This article will cover the rationale behind rebranding, latest statistics, and the roles of pharmacists…
2018 Management of Hypertension (5th Edition)
Last updated onOthers
MPS-YPC 2020/2021 Chairperson Remarks
Last updated onCOVID-19 Treatment Updates: Remdesivir’s Coming To Malaysia, and KKM Releases Latest Treatment Guidelines
Last updated onOperation Vaccination: Yay or Nay? [Updated]
Last updated on2019 New Year Resolution: Have a Pair of Healthier Lungs?
Last updated onHere is a reminder to the smoking ban at eateries which will be officially implemented in 3 days’ time. Like many other laws, it has garnered mixed reactions and divided opinions from the public. Since its announcement back in October, many were sceptical and doubtful on the substance of this. Was the law really going…
FIPYPG’s 20th Anniversary
Last updated onWith new digital technologies growing increasingly involved in contemporary healthcare, an upcoming symposium aims to place the implications for patient welfare at the centre of the discussion. This October, the third edition of the Malaysian Innovative Healthcare Symposium 2018 (MIHS 2018) will bring together healthcare professionals to explore the potential of current and upcoming…